Current methodologies to create monoclonal cell lines include limiting dilution or single-cell sorting at conditions that offer statistical assurance of monoclonality. We have implemented an automated, high-throughput imaging workflow that acquires brightfield and fluorescent images of every well during the single-cell cloning process. These images can provide direct evidence on whether the cell line originated from one cell during the cloning step. Characterization of the workflow was completed, including the effect of fluorescent dye on cell culture, effect of exposure to high intensity light on cell culture and rate of random mutagenesis in the presence of fluorescent dye and high intensity light exposure. Further characterization by flu...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
A regulatory requirement for the production of therapeutic proteins from mammalian cells is that the...
The development of a successful biologic therapeutic manufacturing process begins with the creation ...
<p>Regulations for cell line development are increasingly more stringent. Providing evidence that a ...
Regulations for cell line development are increasingly more stringent. Providing evidence that a cel...
There is significant pressure in the biopharmaceutical industry to reduce timelines from DNA to IND,...
Genomic approaches provide enormous amounts of raw data with regard to genetic variation, the divers...
Automated workflows in clinical and commercial cell line development (CLD) increase efficiency, cons...
Clonality is a key element of cell line development and is an important component of a regulatory su...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Stable cell lines are widely used in laboratory research and pharmaceutical industry. They are mainl...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Stable cell lines are widely used in laboratory research and pharmaceutical industry. They are mainl...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells requires the generation of ...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
A regulatory requirement for the production of therapeutic proteins from mammalian cells is that the...
The development of a successful biologic therapeutic manufacturing process begins with the creation ...
<p>Regulations for cell line development are increasingly more stringent. Providing evidence that a ...
Regulations for cell line development are increasingly more stringent. Providing evidence that a cel...
There is significant pressure in the biopharmaceutical industry to reduce timelines from DNA to IND,...
Genomic approaches provide enormous amounts of raw data with regard to genetic variation, the divers...
Automated workflows in clinical and commercial cell line development (CLD) increase efficiency, cons...
Clonality is a key element of cell line development and is an important component of a regulatory su...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Stable cell lines are widely used in laboratory research and pharmaceutical industry. They are mainl...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Stable cell lines are widely used in laboratory research and pharmaceutical industry. They are mainl...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
Biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells requires the generation of ...
The selection of high-producing mammalian cell lines is a crucial step in process development for th...
A regulatory requirement for the production of therapeutic proteins from mammalian cells is that the...
The development of a successful biologic therapeutic manufacturing process begins with the creation ...